Abstract
The scaffolding A-kinase anchoring protein 150 (AKAP150) is critically involved in kinase and phosphatase regulation of synaptic transmission/plasticity, and neuronal excitability. Emerging evidence also suggests that AKAP150 signaling may play a key role in brain’s processing of rewarding/aversive experiences, however its role in the lateral habenula (LHb, as an important brain reward circuitry) is completely unknown. Using whole cell patch clamp recordings in LHb of male wildtype and ΔPKA knockin mice (with deficiency in AKAP-anchoring of PKA), here we show that the genetic disruption of PKA anchoring to AKAP150 significantly reduces AMPA receptor-mediated glutamatergic transmission and prevents the induction of presynaptic endocannabinoid-mediated long-term depression in LHb neurons. Moreover, ΔPKA mutation potentiates GABAA receptor-mediated inhibitory transmission while increasing LHb intrinsic excitability through suppression of medium afterhyperpolarizations. ΔPKA mutation-induced suppression of medium afterhyperpolarizations also blunts the synaptic and neuroexcitatory actions of the stress neuromodulator, corticotropin releasing factor (CRF), in mouse LHb. Altogether, our data suggest that AKAP150 complex signaling plays a critical role in regulation of AMPA and GABAA receptor synaptic strength, glutamatergic plasticity and CRF neuromodulation possibly through AMPA receptor and potassium channel trafficking and endocannabinoid signaling within the LHb.
Similar content being viewed by others
Introduction
The scaffold protein A-kinase anchoring protein 79/150 (AKAP150, 79 human/150 rodent/Akap5 gene) is a crucial regulator of synaptic receptor trafficking, synaptic transmission and plasticity, and neuronal excitability by anchoring protein kinases (e.g., protein kinase A, PKA, and protein kinase C, PKC) and phosphatases (e.g., calcineurin, CaN) and other signaling molecules (e.g., the transcription factor nuclear factor of activated T-cells, NFAT) to subcellular nanodomains at specific synapses (glutamatergic and GABAergic)1,2,3,4,5,6,7,8,9 and ion channels [e.g., M-type potassium channels, A-type potassium channels, transient receptor potential vanilloid 1 and L-type calcium channels]10,11,12,13,14,15,16. AKAP150 anchoring of PKA, PKC and CaN has been shown to mediate the opposing effects of these enzymes in postsynaptic trafficking of both AMPA receptors (AMPARs) and GABAA receptors (GABAARs) during glutamatergic and GABAergic plasticity1,2,3,4,5,6,7,8,9. For example, phosphorylation of GluA1 subunit of AMPARs with AKAP150-anchored PKA is required for stabilization and insertion of AMPARs in the synapse and promotion of long-term potentiation, while AKAP-anchored CaN dephosphorylates GluA1 subunit of AMPARs and removes AMPARs from the synapse which is required for long-term depression (LTD) in hippocampal CA1 neurons17. Similarly, transient recruitment of GluA2-lacking calcium permeable AMPARs (CP-AMPARs) through phosphorylation coordinated by AKAP150/PKA/CaN is required along with NMDA receptors (NMDARs) not only for the induction of input-specific long-term potentiation and LTD but also for homeostatic plasticity (synaptic scaling) in the hippocampus9,18,19.
In spite of the increasing in-depth mechanistic insights into the role of AKAP150 complex in hippocampal-related learning and memory processes, less is known about the normal and pathological roles of AKAP150 complex-dependent signaling in neural processes within reward-related brain circuits that could contribute to reward-related behaviors as well as in the development of neurological and neuropsychiatric illnesses. This is an important area of psychiatric research as human studies of polymorphisms of AKAP5 also indicate that individuals carrying AKAP5 polymorphisms show altered emotional processing and behavioral responses including aggression, expression of anger and impulsivity associated with alterations in the function in limbic regions20,21,22. Moreover, copy number variations in AKAP5 have been found in DNA samples of schizophrenia patients but not in control subjects23, suggesting the possible involvement of AKAP5 in the pathogenesis of schizophrenia, a neurodevelopmental disorder also linked to reward circuit dysfunction and high rates of addiction24,25,26. Consistently, in recent years a few studies highlighted the importance of AKAP150 signaling within the ventral tegmental area (VTA)8,27,28,29, nucleus accumbens30,31,32, amygdala33,34 and periaqueductal gray15 in regulation of synaptic plasticity and the development of depressive states, aversive and drug-related behaviors.
Here, we attempted to address the potential impact of AKAP150-anchored PKA on the lateral habenula (LHb); an anti-reward brain region hub that regulates midbrain monoaminergic centers and is involved in reward/motivation, mood regulation and decision-making. Accumulating evidence indicate that LHb hyperactivity plays an instrumental role in pathophysiology of depression and possibly other mood disorders and substance use disorders, thus LHb is gaining interest as a potential target for neuromodulation and antidepressants35,36,37,38. LHb neurons are excited by aversive and unpleasant events or the absence of expected reward, and inhibited by unexpected reward, encoding behavioral avoidance and reward prediction errors through suppression of VTA dopamine and dorsal raphe nucleus serotonin systems35,36. The majority of LHb neurons are believed to be glutamatergic and long-range projecting, although local glutamatergic and GABAergic connections within the LHb are reported39,40,41,42. LHb neurons receive glutamatergic, GABAergic and co-releasing glutamate/GABA inputs from the basal ganglia and diverse limbic areas including medial prefrontal cortex, entopeduncular nucleus, lateral preoptic area, lateral hypothalamus, ventral pallidum, medial and lateral septum, central amygdala, bed nucleus of stria terminals as well as receiving reciprocal inputs from the VTA and periaqueductal gray. LHb projects to the substantia nigra, VTA, rostromedial tegmental area (RMTg), dorsal raphe nucleus, locus coeruleus and periaqueductal gray35,43. The majority of the glutamatergic output of LHb exerts a potent feedforward inhibitory influence on monoaminergic systems including VTA dopamine neuronal activity by excitation of GABAergic interneurons and of GABAergic neurons of the RMTg44,45,46,47.
LHb hyperactivity is found to be a common finding associated with anhedonia, lack of motivation and social withdrawal which reflect some of the core features of reward deficits seen in clinical depression36,48,49,50. In general, LHb dysfunction can mediate negative affective states, social deficits, risky decision-making and impulsivity (as shown in patients with depression, schizophrenia, Parkinson’s disease and attention-deficit hyperactivity disorder)36,48,49,50,51,52,53,54,55,56. Given the known postsynaptic PKA-mediated control of LHb synaptic function and intrinsic excitability by neuromodulatory actions of corticotropin releasing factor (CRF)-CRF receptor 1 signaling that acts via cAMP and PKA57, here we investigated the potential impact of AKAP150-anchored PKA on LHb synaptic and neuronal function and CRF neuromodulation within the LHb using whole-cell patch clamp recordings and AKAP150ΔPKA knockin mouse model (hereafter referred to as ΔPKA mice)14. The ΔPKA mice have an internal deletion of ten amino acids within the PKA-RII subunit binding domain near the AKAP C terminus. For AKAP150 complex-related studies, they are advantageous compared to AKAP150 knockout mice as the mutation only affects AKAP150-anchoring of PKA without disrupting other AKAP150 interactions14. We found that the genetic disruption of PKA anchoring to AKAP150 significantly altered both AMPAR- and GABAAR-mediated synaptic transmission and impaired the induction of an endocannabinoid (eCB)-mediated LTD in LHb neurons. Moreover, we observed that ΔPKA mutation enhanced LHb intrinsic excitability which then blunted the excitatory effects of CRF on LHb neuronal activity. Given the multifaceted impact of AKAP150 anchoring of PKA in regulation of glutamatergic transmission and plasticity and neuronal excitability of LHb as well as alteration of CRF regulation of LHb excitability, our data suggest a key role for the AKAP150 complex in normal LHb function and potential contributions of defective AKAP150-mediated PKA anchoring to aberrant LHb activity, dysregulation of CRF neuromodulation within LHb circuits, and hence mood dysregulation.
Results
AKAP150 expression in the LHb
Figure 1 depicts a representative 40x image of LHb of a young adult male mouse taken at AP location (−1.34 relative to bregma). We observed wide expression of AKAP150 in the LHb at three AP locations (−1.06, −1.34 and −1.46) in 4 wild type (WT) mice.
Effects of AKAPΔPKA mutation on synaptic transmission and glutamatergic LTD in LHb neurons
To examine the effects of genetic disruption of PKA anchoring to AKAP150 on AMPAR and GABAAR-mediated synaptic transmission, we recorded either mEPSCs (Fig. 2) or mIPSCs (Fig. 3) from LHb neurons from WT and ΔPKA mice with deficiency in PKA-anchoring to AKAP15014. ΔPKA mutation significantly decreased the average amplitude (inset in Fig. 2b), frequency (inset in Fig. 2c) and charge transfer (inset in Fig. 2d) of mEPSCs and correspondingly shifted the cumulative probability curves of mEPSC amplitude (to the left indicative of smaller amplitude, Fig. 2b), inter-event interval (IEI, to the right indicative of lower frequency, Fig. 2c) and charge transfer (to the left indicative of lower charge transfer, Fig. 2d) without altering mEPSC tau decay (Fig. 2, two-tailed unpaired Student’s t-tests, Kolmogorov-Smirnov tests, p < 0.05, p < 0.01, p < 0.001, p < 0.0001), suggesting both pre- and postsynaptic suppression of glutamatergic transmission in LHb neurons. Only the cumulative probability curve of mIPSC amplitude (Fig. 3b) was significantly shifted to the right by this genetic AKAP-PKA disruption, which may indicate an increase in postsynaptic GABAAR function at a subset of GABAergic synapses onto LHb neurons (Fig. 3, Kolmogorov-Smirnov tests, p < 0.0001). All other mIPSC properties were not significantly different between ΔPKA and WT.
Previously, it has been reported that low frequency stimulation (LFS) can induce a retrograde presynaptic eCB-mediated LTD of the AMPAR-mediated electrically-evoked EPSCs in LHb neurons by postsynaptic activation of group I metabotropic glutamate receptors58 or through calcium-permeable AMPARs (CP-AMPARs) that further activate NMDARs59,60. Here, we also used an identical LFS protocol to induce a presynaptic LTD and assessed the paired pulse ratios (PPRs) and the inverse square of the coefficient of variation (CV = SD/mean; 1/CV2) values as the two main indicators of presynaptic expression of synaptic plasticity. As shown in Fig. 4, the LTD protocol strongly induced eCB-LTD onto LHb neurons in WT mice (Figs. 4a, c) which was associated with significant increases in PPRs (Fig. 4d) and corresponding decreases in 1/CV2 (Fig. 4e) suggesting the expression of eCB-mediated LTD. On the other hand, LHb neurons from ΔPKA mice (Figs. 4b, c) were unable to express this retrograde presynaptic glutamatergic LTD (Fig. 4, LTD: WT, F (1.53, 6.67) = 16.76; ΔPKA: F (1.32, 4.24) = 1.04, p = 0.39, Mixed-effects ANOVA. PPRs and I/CV2: unpaired Student’s t-test, p < 0.01, p < 0.05).
Effects of AKAPΔPKA mutation on LHb intrinsic excitability
Given that PKA regulation of various ion channels in the neuronal membrane requires anchoring of PKA by AKAP15061, it was possible that the genetic disruption of PKA-AKAP association in ΔPKA mice could also impact intrinsic plasticity through changes in trafficking and/or function of a number of voltage-gated channels. Consistently, we observed that LHb neurons of ΔPKA mice exhibited significantly higher intrinsic excitability in the absence of synaptic transmission compared to those from WT mice (Fig. 5a). Furthermore, ΔPKA mutation-induced intrinsic plasticity was associated with lower amplitude of medium afterhyperpolarizations (mAHPs) (Fig. 5d), and shorter AP half widths (Fig. 5g) suggesting that the genetic disruption of AKAP150-PKA anchoring modified intrinsic active and passive neuronal membrane properties, which could also influence synaptic conductance (Fig. 5a–g, intrinsic excitability: F (1, 209) = 21.22, 2-way ANOVA; mAHPs and AP half-width: unpaired Student’s t test, p < 0.05, p < 0.01, p < 0.0001).
Effects of AKAPΔPKA mutation on CRF neuromodulation within the LHb
Previously, we demonstrated that the LHb is a highly CRF-responsive brain region with PKA-dependent regulation of LHb synaptic inhibition and intrinsic excitability. We showed that CRF acting through postsynaptic CRF receptor 1 and cAMP-PKA signaling increases LHb excitability through PKA-dependent suppression of small conductance potassium SK channel activity, as well as presynaptic GABA release via retrograde eCB-CB1 receptor signaling in rat LHb neurons without any significant alterations in glutamatergic transmission57. In contrast to our earlier findings in rat LHb where exogenous CRF did not alter mEPSCs, CRF bath application significantly decreased the average frequency of mEPSCs (inset in Fig. 6c) and correspondingly shifted the cumulative probability curves of mEPSC IEI to the right (Fig. 6c) (Fig. 6, paired Student’s t-tests, Kolmogorov-Smirnov tests, p < 0.05, p < 0.0001), suggesting of CRF-induced suppression of presynaptic glutamate release in mouse LHb neurons.
This diminishing effect of CRF on presynaptic glutamate release was absent in LHb neurons of ΔPKA mice and we even detected a slight but significant leftward shift in the cumulative probability curves of mEPSC IEI (Fig. 7c) that may suggest an unmasked potentiating effects of CRF on presynaptic glutamate release upon disruption of AKAP150-PKA association (Fig. 7, Kolmogorov-Smirnov tests, p < 0.05).
In contrast, we observed similar effects of the ΔPKA mutation on GABAergic transmission in mouse LHb and rat LHb; exogenous CRF significantly diminished the average frequency of mIPSCs (inset in Fig. 8c) and resulted in a significant shift in the cumulative probability curves of mIPSC IEI to the right (Fig. 8c) (Fig. 8, paired Student’s t-tests, Kolmogorov-Smirnov tests, p < 0.05, p < 0.0001), indicating CRF-induced suppression of presynaptic GABA release onto mouse LHb neurons. This diminishing effect of CRF on presynaptic GABAergic transmission remained intact in LHb neurons of ΔPKA mice as evident with a smaller but still significant rightward shift in the cumulative probability curves of mIPSC IEI (Fig. 9c). However, CRF additionally decreased the average amplitude (inset in Fig. 9b) and charger transfer (inset in Fig. 9d) of mIPSCs as well as shifted their corresponding cumulative probability curves of mIPSC amplitude (Fig. 9b) and charge transfer (Fig. 9d) to the left. These results may indicate that CRF alters postsynaptic function and/or trafficking of GABAARs upon disruption of AKAP150-PKA association, potentially favoring AKAP150-dependent regulation of anchored PKC and/or CaN phosphatase activity, both of which can negatively regulate postsynaptic GABAARs29,62, downstream of CRF-CRFR-PKC signaling63,64 (Fig. 9, paired Student’s t-tests, Kolmogorov-Smirnov tests, p < 0.05, p < 0.0001).
In a subset of the neurons represented in Fig. 5a, we were also able to examine the effects of CRF bath application on LHb intrinsic excitability in slices from WT and ΔPKA mice (i.e., intrinsic excitability recordings before and after CRF bath application). Similar to our earlier findings in rat LHb57, CRF bath application exerted similar effects on intrinsic excitability and intrinsic membrane properties of male mouse LHb. We found that CRF significantly increased LHb intrinsic excitability (with blocked fast AMPAR, NMDAR and GABAAR-mediated transmission) (Fig. 10a, b) coincident with higher input resistance (Fig. 10c), reduced levels of mAHPs (Fig. 10e), lower AP threshold (Fig. 10f) and smaller AP amplitudes (Fig. 10g) in LHb neurons. The only exception was that CRF-induced increases in fAHPs were not observed in mouse LHb (Fig. 10d) (Fig. 10a–h, 2-way repeated-measures ANOVA, F (1, 7) = 8.23, p < 0.05). On the other hand, we observed that the excitatory actions of CRF in LHb of ΔPKA mice were absent (Fig. 10i–j), although CRF was able to increase the amplitude of fAHPs (Fig. 10l) in LHb neurons of ΔPKA mice (Fig. 10i–p, 2-way repeated-measures ANOVA, F (1, 6) = 0.4436, p = 0.53).
Discussion
Most of our understanding of the role of AKAP150 in the brain relates to hippocampal studies but emerging evidence also suggests important roles for AKAP150 in reward-related brain regions critical for the control of mood, motivation, reward, and stress responses8,15,27,28,29,30,31,33,34. Here, we uncovered a multifaceted essential regulatory role of AKAP150 in synaptic function, neuronal activity, and CRF neuromodulatory actions within the LHb using the ΔPKA knock-in mouse model with a deficiency of AKAP150 anchoring of PKA. We found that in LHb neurons AKAP150-anchored PKA is required for postsynaptic regulation of AMPAR trafficking and/or function at glutamatergic synapses and for the expression of glutamatergic retrograde presynaptic eCB-LTD. In contrast, AKAP150-PKA signaling may provide an inhibitory feedback mechanism for postsynaptic trafficking and/or function of GABAARs or regulate gene expression programs that indirectly control inhibitory synaptic strength65. Moreover, we found that defects in AKAP150-PKA mediated expression, trafficking, and/or gating of potassium channels that regulate LHb excitability could blunt CRF neuromodulatory effects within the LHb.
Postsynaptic AMPAR and GABAAR trafficking and function are necessary for maintaining basal synaptic transmission as well as induction and expression of synaptic plasticity which can be altered through phosphorylation-dephosphorylation processes that require AKAP15061. There are four subunits of AMPARs (GluA1–GluA4) of which LHb neurons express high levels of GluA1-containing rectifying AMPARs that lack GluA2 (also called calcium-permeable, CP-AMPARs with fast kinetics, high conductance and strong inward rectification) but also express low levels of both GluA2-containing AMPARs (with slower kinetics, low conductance and impermeability to calcium) and NMDARs at their glutamatergic synapses66,67. AKAP150-anchored PKA is shown to phosphorylate Ser-845 on the GluA1 subunit of CP-AMPARs to increase membrane trafficking of AMPARs at glutamatergic synapses, while AKAP150-anchored PKC, through phosphorylation of Ser-831 on GluA1 further results in emergence of CP-AMPARs at synapses68. In the LHb, it has been shown that cocaine can induce synaptic potentiation and hyperexcitability in LHb neurons projecting to RMTg (LHb→RMTg neurons) through Ser-845 phosphorylation of GluA1 that increases trafficking of GluA1 AMPARs in LHb→RMTg neurons69. Additionally, phosphorylation of Ser-831 on the GluA1 subunit of AMPARs by β-calcium/calmodulin-dependent kinase type II in the LHb is shown to promote GluA1 AMPAR insertion into synapses and glutamatergic potentiation, resulting in LHb hyperactivity and behavioral depression70. Given that the knockin mutation in ΔPKA mice leads to reductions in postsynaptic PKA localization in dendritic spines14, our observation of lower levels of mEPSC amplitude and charge transfer in ΔPKA mice is most likely due to decreased PKA-dependent Ser-845 phosphorylation of GluA1 rectifying AMPARs by the genetic disruption of AKAP150 anchoring of PKA to GluA1. Note that the decrease in frequency of mEPSC in ΔPKA mice is likely postsynaptic, related to an increase in the number of silent synapses following the loss of AMPARs at the synapse71 rather than a change in presynaptic glutamate release. Whether, the upregulation of calcium–calmodulin-dependent protein kinase II-regulated AKAP79/150 depalmitoylation that is important in AKAP150 removal from dendritic spine and structural LTD72 is favored in ΔPKA mice is an open question.
Interestingly, disruption of PKA anchoring in ΔPKA mice is shown to impair an NMDAR-dependent LTD induced by prolonged LFS (1 Hz, 15 min similar to the LTD protocol in LHb) in CA1 hippocampal neurons of 2-week-old mice due to decreased S845 phosphorylation of CP-AMPARs in ΔPKA mice that prevents the AKAP150-PKA-dependent transient recruitment of CP-AMPARs to the synapse that is required for hippocampal LTD induction9. Interestingly, LFS can also induce eCB-mediated LTD in the LHb through increased activity of CP-AMPAR (as a major source of calcium) that further engages NMDARs to trigger retrograde eCB-LTD59,60. Given that the majority of AMPARs in the LHb are CP-AMPARs, a reduced level of CP-AMPARs in LHb neurons of ΔPKA mice could result in lower levels of depolarization and postsynaptic calcium needed for eCB production, thereby deficits in induction and expression of eCB-LTD. Moreover, since basal PKA phosphorylation of L-type calcium channels (LTCC) is necessary for depolarization-induced activation of LTCCs, the ΔPKA mutation could further diminish Ca2+ influx through LTCC as an unopposed CaN activity can dephosphorylate LTCCs14. This in addition to the presence of fewer CP-AMPARs in LHb neurons of ΔPKA mice might result in further reduction in Ca2+ influx, defective eCB production, and hence impaired eCB-LTD in LHb neurons.
GABAARs at GABAergic synapses onto LHb neurons are mainly composed of a combination of the α1-3, β1 and γ1-2 subunits73. There is less known about PKA-dependent regulation of GABAARs in the LHb. Our previous study in VTA dopamine neurons suggests that activation of dopamine D2 receptors results in PKA inhibition that promotes AKAP150-CaN-mediated internalization of GABAAR receptors and the expression of LTD at GABAergic synapses onto VTA dopamine neurons29. The expression of an inhibitory metabotropic glutamate receptor-dependent postsynaptic LTD at GABAergic synapses onto LHb neurons requires a PKC-dependent phosphorylation of the β2 receptor subunits of GABAARs, reducing GABAAR single-channel conductance58. This also excludes the possibility that a biased AKAP150-PKC signaling in the absence of AKAP-PKA association in ΔPKA mice could promote the basal increase in the conductance of GABAARs in LHb neurons. Therefore, it is still an open question which AKAP150 associations with other binding partners could promote forward trafficking of GABAARs in LHb neurons.
In addition to alterations of synaptic transmission and LTD by ΔPKA mutation, we observed a significant increase in LHb intrinsic excitability associated with higher input resistance and lower amplitude of mAHPs, mimicking the effects of exogenous CRF (as we observed in both mouse and rat LHb) and after a severe early like stress (i.e., maternal deprivation)57. However, the diminishing effects of exogenous CRF and maternal deprivation on mAHPs and the resultant hyperexcitability were due to the PKA-dependent decrease in the function and/or abundance of SK channels57, a mechanism that is less likely to underlie ΔPKA mutation-induced LHb intrinsic plasticity. Afterhyperopolarizations including fAHPs and mAHPs are mediated by diverse types of potassium channels that repolarize the membrane to regulate and limit excessive neuronal excitability. In addition to SK channels, voltage gated K+ channel 7 (Kv7, also known as M currents) contribute to mAHP in neurons74. Therefore, it is possible that genetic disruption of AKAP150 anchoring of PKA in ΔPKA favors AKAP150-anchored PKC and the resultant inhibition of M-type mAHPs12 to increase LHb intrinsic excitability in ΔPKA mice, which could saturate and occlude the excitatory actions of CRF on LHb intrinsic excitability. Consistent with this interpretation, it has been shown that activation of LHb M channels reduces LHb neuronal activity and blocks the anxiety-like phenotype in alcohol-withdrawn rats75. Given that that the majority of synaptic inputs to the LHb co-release glutamate and GABA40, our observation of CRF-induced suppression of both presynaptic glutamate and GABA release in mouse LHb is not surprising as CB1 receptors are expressed on presynaptic terminals in the LHb where CB1 receptor activation by eCBs can reduce the probability of presynaptic glutamate and GABA release onto LHb neurons at distinct synaptic inputs to the LHb (e.g., lateral preoptic area) although the effect on presynaptic GABA release is assumed to be predominantly larger76. The ΔPKA mutation to some extent reduced the suppressing effects of CRF on presynaptic GABA release but also unmasked a small potentiating effect of CRF on presynaptic glutamate release. This could be due to decreased depolarization and/ or Ca2+ influx from the fewer CP-AMPARs available at the synapse as well as the less effective influx of Ca2+ from hypofunctional LTCCs in ΔPKA mice, which could in turn lead to dysregulation of eCB production that not only prevented the expression of eCB-LTD but also blunted the inhibitory effects of CRF on synaptic transmission by shifting excitation/inhibition balance to more excitation. Therefore, we assume that disruption of AKAP150 anchoring of PKA seems to promote LHb hyperexcitability through synaptic and intrinsic mechanisms that may relate to the lack of AKAP150-dependent PKA-mediated signaling as well as favoring unopposed non-PKA-mediated AKAP150 interactions. These concepts are briefly summarized in Supplementary Fig. 1, which depicts in schematic representing GABAergic and glutamatergic terminals innervating a spine and dendritic shaft of an LHb neuron. Sites in this synaptic complex where AKAP-mediated signaling plays a potential role in synaptic function and plasticity are indicated.
Overall, our study highlights the important and multifaceted impacts of AKAP150 anchoring of PKA in the regulation of glutamatergic transmission and plasticity, and neuronal excitability of LHb neurons. Moreover, defects in AKAP150-mediated PKA anchoring under pathological processes could favor other, yet to-be-discovered, AKAP150 interactions in LHb neurons that promote LHb hyperactivity and dysregulate CRF neuromodulation within the LHb, reminiscent of the effects of a severe early life stress57 and alcohol withdrawal77,78. Considering that human studies of polymorphisms of in the AKAP5 gene indicate an essential role for this AKAP in emotional regulation and cognitive control of anger, aggression and impulsivity20,21,22,23, it will be important to establish a direct link between the physiological and behavioral effects of such genetic variants or mutations of AKAP5 with LHb circuit activity and LHb-regulation of emotionally motivated behaviors, behavioral impulsivity and aggression35,38,79,80.
It is worth mentioning that there is a limitation to our genetic approach in which ΔPKA mutation is not confined to the LHb of ΔPKA mice. This raises the possibility that our current synaptic observations may not be solely limited to direct disruption of AKAP150-PKA complex signaling within the LHb of ΔPKA mice; but also involve dysregulation of AKAP150-PKA-mediated synaptic or neuromodulatory functions within brain areas that directly project to the LHb such as medial prefrontal cortex, VTA, amygdala and periaqueductal gray where AKAP150/PKA signaling is known to regulate synaptic mechanisms underlying impulsive, depressive-, aversive- and drug-related behaviors8,15,27,28,29,33,34,81.
Future studies are further needed to increase our understanding of cell-type and input-specific neuroplasticity and neuromodulation through alterations in LHb AKAP150 complex interactions within LHb circuits in neurological and neuropsychiatric illnesses.
Methods
Animals
All experiments were carried out using 5-7wk old male WT (C57/Bl6) and ΔPKA mice in accordance with the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals and were approved by the Uniformed Services University and the University of Colorado (Denver) Institutional Animal Care and Use Committees. AKAP150ΔPKA knockin mice were generated as previously described14. We have complied with all relevant ethical regulations for animal use. Briefly, we constructed a targeting vector for the deletion of 30 bp encoding 709-LLIETASSLV-718 that was introduced into the single coding exon of an Akap5 genomic DNA fragment subcloned from a C57BL/6 bacterial artificial clone. In this targeting vector, the ΔPKA mutation and a C-terminal myc-epitope tag were introduced with a loxP-flanked-neomycin resistance cassette inserted into the 3” flanking genomic DNA. Following electroporation of the targeting vector into a hybrid C57BL/6-129 embryonic stem cell. Targeted G418-resistant clones were screened for homologous recombinants by PCR. The positive clones were expanded and injected into blastocysts and transplanted into surrogate mothers. Chimeric F0 founders were born and subsequently bred to C57BL/6 to establish germ-line transmission. Inter-crossing of F1 mice that were heterozygous for the ΔPKA mutation yielded F2 ΔPKA homozygotes. Mice were bred by Dell’Acqua laboratory at the University of Colorado Anschutz Medical Campus in Aurora, CO and shipped to Nugent laboratory at the Uniformed Services University in Bethesda, MD at ages between ~28–35 days old. After a week in quarantine at animal facility, mice were used for electrophysiology experiments. Given the concern regarding the possible higher stress levels of juvenile female mice in estrus phase during the shipment and the possibility of stress-induced hormonal dysregulation of LHb activity (a subpopulation of GABAergic interneurons are found to express estrogen receptor-alpha (ERα)(termed the GABAergic estrogen-receptive neuron or GERN)39,41), we decided to only use male mice for this study and plan for having a colony at both sites for our future collaborative studies. Mice were grouped and housed in standard cages under a 12 hr/12 hr light-dark cycle with standard laboratory lighting conditions (lights on, 0600-1800), with ad libitum access to food and water. All procedures were conducted beginning 2–4 hr after the start of the light-cycle. All efforts were made to minimize animal suffering and reduce the number of animals used throughout this study.
Slice preparation
For all electrophysiology experiments, several separate cohorts of WT/ ΔPKA mice were used. All mice were anesthetized with isoflurane, decapitated and brains were quickly dissected and placed into the ice-cold artificial cerebrospinal fluid (ACSF) containing (in mM): 126 NaCl, 21.4 NaHCO3, 2.5 KCl, 1.2 NaH2PO4, 2.4 CaCl2, 1.00 MgSO4, 11.1 glucose, 0.4 ascorbic acid; saturated with 95% O2−5% CO2 as previously described82. Sagittal slices containing LHb were cut at 220 µm using a vibratome (Leica; Wetzler, Germany) and incubated in above prepared ACSF at 34 °C for at least 1 h prior to electrophysiological experiments. Slices were then transferred to a recording chamber and perfused with ascorbic-acid free ACSF at 28 °C.
Electrophysiology
All whole-cell recordings were performed on LHb-containing slices using patch pipettes (3–6 MOhms) and a patch amplifier (MultiClamp 700B) under infrared-differential interference contrast microscopy. Data acquisition and analysis were carried out using DigiData 1440 A, pCLAMP 10 (Molecular Devices), Clampfit, Origin 2016 (OriginLab), Mini Analysis 6.0.3 (Synaptosoft Inc.) and GraphPad Prism 10. Signals were filtered at 3 kHz and digitized at 10 kHz. In all of our recordings, the cell input resistance and series resistance were monitored through the experiment and if these values changed by more than 10%, data were not included.
Whole-cell recordings of AMPAR-mediated miniature excitatory postsynaptic currents (mEPSCs) were isolated in ACSF perfused with GABAAR antagonist picrotoxin (100 µM, Tocris-1128), NMDAR antagonist D-(-)−2-Amino-5- phosphonopentanoic acid (APV 50 µM, Tocris-0106) and tetrodotoxin (1 μM Tocris-1078) and internal solution containing 117 mM Cesium-gluconate, 2.8 mM NaCl, 5 mM MgCl2, 2 mM ATP-Na+, 0.3 mM GTP-Na+, 0.6 mM EGTA, and 20 mM HEPES (pH 7.28, 275–280 mOsm). Whole-cell recordings of GABAAR-mediated miniature inhibitory postsynaptic currents (mIPSCs) were isolated in ACSF perfused with the AMPAR antagonist 6,7 dinitroquinoxaline-2,3-dione di-sodium salt (10 μM Tocris- 2312/10), strychnine (1 μM Tocris-2785) and tetrodotoxin (1 μM). Patch pipettes were filled with 125 mM KCl, 2.8 mM NaCl, 2 mM MgCl2, 2 mM ATP-Na+, 0.3 mM GTP-Na+, 0.6 mM EGTA, and 10 mM HEPES (pH 7.28, 275–280 mOsm). For both mIPSCs and mEPSCs, LHb neurons were voltage-clamped at −70 mV and recorded over 10 sweeps, each lasting 50 seconds.
In some experiments, electrically-evoked AMPAR-mediated EPSCs were isolated and recorded using ACSF containing picrotoxin (100 μM). The patch pipettes were filled with cesium-gluconate based solution as described above for mEPSC recordings. Cells were voltage-clamped at −70 mV, except during LTD protocol. Paired AMPAR-mediated EPSCs were stimulated at 0.1 Hz (100 ms) using a bipolar stainless steel stimulating electrode placed ~200–400 µm from the recording site in stria medularis in LHb slices. The stimulation intensity was adjusted so that the amplitude of synaptic responses ranged about ~50% of the maximum response. LTD was induced using low-frequency stimulation, LFS, 1 Hz for 15 min while LHb neurons were voltage-clamped at −40 mV.
To assess LHb intrinsic excitability and membrane properties, LHb slices were perfused with ascorbic-free ACSF and patched with potassium gluconate-based internal solution (130 mM K-gluconate, 15 mM KCl, 4 mM ATP-Na+, 0.3 mM GTP-Na+, 1 mM EGTA, and 5 mM HEPES, pH adjusted to 7.28 with KOH, osmolarity adjusted to 275 to 280 mOsm). LHb intrinsic excitability experiments were performed with fast-synaptic transmission blockade by adding the AMPAR antagonist 6,7 dinitroquinoxaline-2,3-dione di-sodium salt (10 µM), GABAAR blocker picrotoxin (100 µM), and NMDAR antagonist D-(-)−2-Amino-5- phosphonopentanoic acid (50 µM) to the ACSF. LHb neurons were given increasingly depolarizing current steps at +10pA intervals ranging from +10pA to +100pA, allowing us to measure action potential (AP) generation in response to membrane depolarization (5 s duration). Current injections were separated by a 20 s interstimulus interval and neurons were kept at ~−65 to −70 mV with manual direct current injection between pulses. Resting membrane potential (RMP) was assessed immediately after achieving whole-cell patch configuration in the current clamp mode. Input resistance (Rin) was measured during a −50 pA step (5 s duration) and calculated by dividing the steady-state voltage response by the current-pulse amplitude (−50 pA) and presented as MOhms (MΩ). The number of APs induced by depolarization at each intensity was counted and averaged for each experimental group. As previously described57 AP number, AP threshold, fast and medium after-hyperpolarization amplitudes (fAHP and mAHP), AP halfwidth, AP amplitude were assessed using Clampfit and measured at the current step that was sufficient to generate the first AP/s.
Drugs
For all drug experiments, a within-subjects experimental design was employed. Stock solutions for CRF were prepared in distilled water and diluted (1:1000) to a final concentration in ACSF of 250 nM. Baseline recordings were first performed (depolarization-induced AP/mIPSC/mEPSC) for each neuron and then CRF (250 nM Tocris-1151) was added to the slice by the perfusate and response tested following 30–45 min of CRF application.
Immunohistochemistry
Mice were anesthetized with an intraperitoneal injection containing ketamine (85 mg/kg) and xylazine (10 mg/kg) and perfused through the aorta with 200 ml of 1x phosphate buffered saline (PBS), followed by 250 ml of 4% paraformaldehyde (Santa Cruz). The brains were dissected and placed in 4% paraformaldehyde for 24 h and then cryoprotected by submersion in 20% sucrose for 3 d, frozen on dry ice, and stored at 70 °C until sectioned. Sections of the LHb were cut using a cryostat (Leica CM1900) and mounted on slides. Serial coronal sections (20 μm) of the midbrain containing the LHb (from −2.64 to −4.36 mm caudal to bregma (Paxinos and Watson, 2007) were fixed in 4% PFA for 5 min, washed in 1x PBS, and then blocked in 10% normal goat serum containing 0.3% Triton X-100 in 1x PBS for 1 h. Sections were incubated in goat anti- AKAP150 antibody (1:500, Santa Cruz Sc-6445) in carrier solution (5% normal goat serum in 0.1% Triton X-100 in 1x PBS) overnight at room temperature. After rinsing in 1x PBS, sections were incubated for 2 h in Alexa Fluor® 488 labeled chicken anti-goat IgG (diluted 1:200). Finally, sections were rinsed in 1x PBS, dried, and coverslipped with prolonged mounting medium containing DAPI to permit visualization of nuclei. Background staining was assessed by omission of primary antibody in the immunolabeling procedure (negative control). Brain tissue sections of mice with a previously established presence of AKAP150 immunoreactive neurons (hippocampus, VTA) were also processed as positive control tissues. Images were captured using a Leica DMRXA Fluorescence microscope.
Statistics and reproducibility
Values are presented as mean ± SEM. Statistical significance was determined using unpaired or paired two-tailed Student’s t-test, two-way ANOVA, or repeated-measures ANOVA/mixed-effects ANOVA with Bonferroni post hoc analysis. The threshold for significance was set at *p < 0.05 for all analyses. The peak values of the evoked paired EPSCs were measured relative to the same baseline. A stable baseline value was considered in each sweep of paired pulses starting at 20-50 ms right before the emergence of the EPSC current using p-Clamp 10 software. The paired-pulse ratio (PPR) was calculated as the amplitude of the second EPSP divided by the amplitude of the first EPSC. The inverse square of the coefficient of variation (CV = SD/mean) was also used as the second measure for identifying the presynaptic expression of plasticity. For calculating the significance of EPSC amplitude changes after LTD induction protocol, amplitudes of EPSCs to the first pulse were used. Mini Analysis software was used to detect and measure mIPSCs and mEPSCs using preset detection parameters of mIPSCs and mEPSCs with an amplitude cutoff of 5 pA. The Kolmogorov–Smirnov test was performed for the statistical analyses of cumulative probability plots of mEPSCs and mIPSCs. All statistical analyses were performed using GraphPad Prism 10.
Reporting summary
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.
Data availability
The raw data generated during this study that support the findings of this study are available on request from the corresponding authors. The raw data are not publicly available due to privacy or ethical restrictions; however, the analyzed dataset and supporting Information reported in the article’s figures are included in Supplementary Data 1.
References
Sanderson, J. L. & Dell’acqua, M. L. AKAP signaling complexes in regulation of excitatory synaptic plasticity. Neuroscientist 17, 321–336 (2011).
Snyder, E. M. et al. Role for A kinase-anchoring proteins (AKAPS) in glutamate receptor trafficking and long term synaptic depression. J. Biol. Chem. 280, 16962–16968 (2005).
Lu, Y. et al. Age-dependent requirement of AKAP150-anchored PKA and GluR2-lacking AMPA receptors in LTP. EMBO J. 26, 4879–4890 (2007).
Lu, Y. et al. AKAP150-anchored PKA activity is important for LTD during its induction phase. J. Physiol. 586, 4155–4164 (2008).
Bhattacharyya, S., Biou, V., Xu, W., Schluter, O. & Malenka, R. C. A critical role for PSD-95/AKAP interactions in endocytosis of synaptic AMPA receptors. Nat. Neurosci. 12, 172–181 (2009).
Jurado, S., Biou, V. & Malenka, R. C. A calcineurin/AKAP complex is required for NMDA receptor-dependent long-term depression. Nat. Neurosci. 13, 1053–1055 (2011).
Sanderson, J. L. et al. AKAP150-anchored calcineurin regulates synaptic plasticity by limiting synaptic incorporation of Ca2 + −permeable AMPA receptors. J. Neurosci. 32, 15036–15052 (2012).
Authement, M. E. et al. Histone deacetylase inhibition rescues maternal deprivation-induced GABAergic metaplasticity through restoration of AKAP signaling. Neuron 86, 1240–1252 (2015).
Sanderson, J. L., Gorski, J. A. & Dell’Acqua, M. L. NMDA receptor-dependent LTD requires transient synaptic incorporation of Ca(2)(+)-permeable AMPARs mediated by AKAP150-anchored PKA and Calcineurin. Neuron 89, 1000–1015 (2016).
Zhang, J. & Shapiro, M. S. Activity-dependent transcriptional regulation of M-Type (Kv7) K(+) channels by AKAP79/150-mediated NFAT actions. Neuron 76, 1133–1146 (2012).
Hoshi, N., Langeberg, L. K. & Scott, J. D. Distinct enzyme combinations in AKAP signalling complexes permit functional diversity. Nat. Cell Biol. 7, 1066–1073 (2005).
Hoshi, N. et al. AKAP150 signaling complex promotes suppression of the M-current by muscarinic agonists. Nat. Neurosci. 6, 564–571 (2003).
Lin, L., Sun, W., Kung, F., Dell’Acqua, M. L. & Hoffman, D. A. AKAP79/150 impacts intrinsic excitability of hippocampal neurons through phospho-regulation of A-type K+ channel trafficking. J. Neurosci. 31, 1323–1332 (2011).
Murphy, J. G. et al. AKAP-anchored PKA maintains neuronal L-type calcium channel activity and NFAT transcriptional signaling. Cell Rep. https://doi.org/10.1016/j.celrep.2014.04.027 (2014).
Bai, X. et al. Selective activation of AKAP150/TRPV1 in ventrolateral periaqueductal gray GABAergic neurons facilitates conditioned place aversion in male mice. Commun. Biol. 6, 742 (2023).
Schnizler, K. et al. Protein kinase A anchoring via AKAP150 is essential for TRPV1 modulation by forskolin and prostaglandin E2 in mouse sensory neurons. J. Neurosci. 28, 4904–4917 (2008).
Tavalin, S. J. et al. Regulation of GluR1 by the A-kinase anchoring protein 79 (AKAP79) signaling complex shares properties with long-term depression. J. Neurosci. 22, 3044–3051 (2002).
Purkey, A. M. & Dell’Acqua, M. L. Phosphorylation-dependent regulation of Ca(2+)-permeable AMPA receptors during hippocampal synaptic plasticity. Front. Synaptic Neurosci. 12, 8 (2020).
Sanderson, J. L., Scott, J. D. & Dell’Acqua, M. L. Control of homeostatic synaptic plasticity by AKAP-anchored kinase and phosphatase regulation of Ca(2+)-permeable AMPA receptors. J. Neurosci. 38, 2863–2876 (2018).
Richter, S. et al. A potential role for a genetic variation of AKAP5 in human aggression and anger control. Front. Hum. Neurosci. 5, 175 (2011).
Suryavanshi, S. V., Jadhav, S. M. & McConnell, B. K. Polymorphisms/mutations in A-kinase anchoring proteins (AKAPs): role in the cardiovascular system. J. Cardiovasc. Dev. Dis. 5 https://doi.org/10.3390/jcdd5010007 (2018).
Richter, S. et al. Effects of AKAP5 Pro100Leu genotype on working memory for emotional stimuli. PLoS One 8, e55613 (2013).
Sutrala, S. R. et al. Gene copy number variation in schizophrenia. Schizophr. Res. 96, 93–99 (2007).
Scheller-Gilkey, G., Moynes, K., Cooper, I., Kant, C. & Miller, A. H. Early life stress and PTSD symptoms in patients with comorbid schizophrenia and substance abuse. Schizophr. Res. 69, 167–174 (2004).
Scheller-Gilkey, G., Thomas, S. M., Woolwine, B. J. & Miller, A. H. Increased early life stress and depressive symptoms in patients with comorbid substance abuse and schizophrenia. Schizophr. Bull. 28, 223–231 (2002).
Winklbaur, B., Ebner, N., Sachs, G., Thau, K. & Fischer, G. Substance abuse in patients with schizophrenia. Dialog. Clin. Neurosci. 8, 37–43 (2006).
Shepard, R. D., Langlois, L. D., Authement, M. E. & Nugent, F. S. Histone deacetylase inhibition reduces ventral tegmental area dopamine neuronal hyperexcitability involving AKAP150 signaling following maternal deprivation in juvenile male rats. J. Neurosci. Res. 98, 1457–1467 (2020).
Shepard, R. D. et al. Targeting histone deacetylation for recovery of maternal deprivation-induced changes in BDNF and AKAP150 expression in the VTA. Exp. Neurol. 309, 160–168 (2018).
Dacher, M., Gouty, S., Dash, S., Cox, B. M. & Nugent, F. S. A-kinase anchoring protein-calcineurin signaling in long-term depression of GABAergic synapses. J. Neurosci. 33, 2650–2660 (2013).
Reissner, K. J. et al. AKAP signaling in reinstated cocaine seeking revealed by iTRAQ proteomic analysis. J. Neurosci. 31, 5648–5658 (2011).
Guercio, L. A. et al. A-kinase anchoring protein 150 (AKAP150) promotes cocaine reinstatement by increasing AMPA receptor transmission in the accumbens shell. Neuropsychopharmacology 43, 1395–1404 (2018).
Bai, X. et al. AKAP150 from nucleus accumbens dopamine D1 and D2 receptor-expressing medium spiny neurons regulates morphine withdrawal. iScience 26, 108227 (2023).
Zhou, H. Y. et al. A-kinase anchoring protein 150 and protein kinase a complex in the basolateral amygdala contributes to depressive-like behaviors induced by chronic restraint stress. Biol. Psychiatry 86, 131–142 (2019).
Moita, M. A., Lamprecht, R., Nader, K. & LeDoux, J. E. A-kinase anchoring proteins in amygdala are involved in auditory fear memory. Nat. Neurosci. 5, 837–838 (2002).
Hu, H., Cui, Y. & Yang, Y. Circuits and functions of the lateral habenula in health and in disease. Nat. Rev. Neurosci. 21, 277–295 (2020).
Proulx, C. D., Hikosaka, O. & Malinow, R. Reward processing by the lateral habenula in normal and depressive behaviors. Nat. Neurosci. 17, 1146–1152 (2014).
Hikosaka, O. The habenula: from stress evasion to value-based decision-making. Nat. Rev. Neurosci. 11, 503–513 (2010).
Baker, P. M. et al. Lateral Habenula beyond avoidance: roles in stress, memory, and decision-making with implications for psychiatric disorders. Front. Syst. Neurosci. 16, 826475 (2022).
Zhang, L. et al. A GABAergic cell type in the lateral habenula links hypothalamic homeostatic and midbrain motivation circuits with sex steroid signaling. Transl. Psychiatry 8, 50 (2018).
Webster, J. F. et al. Disentangling neuronal inhibition and inhibitory pathways in the lateral habenula. Sci. Rep. 10, 8490 (2020).
Zhang, L., Hernandez, V. S., Vazquez-Juarez, E., Chay, F. K. & Barrio, R. A. Thirst is associated with suppression of habenula output and active stress coping: is there a role for a non-canonical vasopressin-glutamate pathway. Front. Neural Circuits 10, 13 (2016).
Margolis, E. B. & Fields, H. L. Mu opioid receptor actions in the lateral habenula. PLoS One 11, e0159097 (2016).
Graziane, N. M., Neumann, P. A. & Dong, Y. A focus on reward prediction and the lateral habenula: functional alterations and the behavioral outcomes induced by drugs of abuse. Front. Synaptic Neurosci. 10, 12 (2018).
Stopper, C. M., Tse, M. T. L., Montes, D. R., Wiedman, C. R. & Floresco, S. B. Overriding phasic dopamine signals redirects action selection during risk/reward decision making. Neuron 84, 177–189 (2014).
Quina, L. A. et al. Efferent pathways of the mouse lateral habenula. J. Comp. Neurol. 523, 32–60 (2015).
Proulx, C. D. et al. A neural pathway controlling motivation to exert effort. Proc. Natl Acad. Sci. USA 115, 5792–5797 (2018).
van Zessen, R., Phillips, J. L., Budygin, E. A. & Stuber, G. D. Activation of VTA GABA neurons disrupts reward consumption. Neuron 73, 1184–1194 (2012).
Cerniauskas, I. et al. Chronic stress induces activity, synaptic, and transcriptional remodeling of the lateral habenula associated with deficits in motivated behaviors. Neuron 104, 899–915 e898 (2019).
Pobbe, R. L. & Zangrossi, H. Jr. Involvement of the lateral habenula in the regulation of generalized anxiety- and panic-related defensive responses in rats. Life Sci. 82, 1256–1261 (2008).
Berger, A. L. et al. The lateral habenula directs coping styles under conditions of stress via recruitment of the endocannabinoid system. Biol. Psychiatry 84, 611–623 (2018).
Lee, Y.-A. & Goto, Y. The Habenula in the Link Between ADHD and Mood Disorder. Front. Behav. Neurosci. 15 https://doi.org/10.3389/fnbeh.2021.699691 (2021).
Li, J. et al. Hypoactivity of the lateral habenula contributes to negative symptoms and cognitive dysfunction of schizophrenia in rats. Exp. Neurol. 318, 165–173 (2019).
Arfuso, M., Salas, R., Castellanos, F. X. & Krain Roy, A. Evidence of altered habenular intrinsic functional connectivity in pediatric ADHD. J. Atten. Disord. 25, 749–757 (2021).
Orsini, C. A., Moorman, D. E., Young, J. W., Setlow, B. & Floresco, S. B. Neural mechanisms regulating different forms of risk-related decision-making: insights from animal models. Neurosci. Biobehav. Rev. 58, 147–167 (2015).
Banwinkler, M., Theis, H., Prange, S. & van Eimeren, T. Imaging the limbic system in Parkinson’s disease—a review of limbic pathology and clinical symptoms. Brain Sci. 12, 1248 (2022).
Zhu, Y. et al. Connectome-based biomarkers predict subclinical depression and identify abnormal brain connections with the lateral habenula and thalamus. Front. Psychiatry 10, 371 (2019).
Authement, M. E. et al. A role for corticotropin-releasing factor signaling in the lateral habenula and its modulation by early-life stress. Sci. Signal. 11, eaan6480 (2018).
Valentinova, K. & Mameli, M. mGluR-LTD at excitatory and inhibitory synapses in the lateral habenula tunes neuronal output. Cell Rep. 16, 2298–2307 (2016).
Park, H., Rhee, J., Lee, S. & Chung, C. Selectively impaired endocannabinoid-dependent long-term depression in the lateral habenula in an animal model of depression. Cell Rep. 20, 289–296 (2017).
Kang, M., Noh, J. & Chung, J. M. NMDA receptor-dependent long-term depression in the lateral habenula: implications in physiology and depression. Sci. Rep. 10, 17921 (2020).
Wild, A. R. & Dell’Acqua, M. L. Potential for therapeutic targeting of AKAP signaling complexes in nervous system disorders. Pharmacol. Ther. https://doi.org/10.1016/j.pharmthera.2017.12.004 (2017).
Herring, D., Huang, R., Singh, M., Dillon, G. H. & Leidenheimer, N. J. PKC modulation of GABAA receptor endocytosis and function is inhibited by mutation of a dileucine motif within the receptor beta 2 subunit. Neuropharmacology 48, 181–194 (2005).
Gutknecht, E., Vauquelin, G. & Dautzenberg, F. M. Corticotropin-releasing factor receptors induce calcium mobilization through cross-talk with Gq-coupled receptors. Eur. J. Pharmacol. 642, 1–9 (2010).
Dautzenberg, F. M. et al. Cell-type specific calcium signaling by corticotropin-releasing factor type 1 (CRF1) and 2a (CRF2(a)) receptors: phospholipase C-mediated responses in human embryonic kidney 293 but not SK-N-MC neuroblastoma cells. Biochem. Pharm. 68, 1833–1844 (2004).
West, A. E. & Greenberg, M. E. Neuronal activity-regulated gene transcription in synapse development and cognitive function. Cold Spring Harb. Perspect. Biol. 3, a005744 (2011).
Maroteaux, M. & Mameli, M. Cocaine evokes projection-specific synaptic plasticity of lateral habenula neurons. J. Neurosci. 32, 12641–12646 (2012).
Li, B. et al. Synaptic potentiation onto habenula neurons in the learned helplessness model of depression. Nature 470, 535–539 (2011).
Bucko, P. J. & Scott, J. D. Drugs that regulate local cell signaling: AKAP targeting as a therapeutic option. Annu. Rev. Pharmacol. Toxicol. 61, 361–379 (2021).
Meye, F. J. et al. Cocaine-evoked negative symptoms require AMPA receptor trafficking in the lateral habenula. Nat. Neurosci. 18, 376–378 (2015).
Li, K. et al. betaCaMKII in lateral habenula mediates core symptoms of depression. Science (New York, N.Y) 341, 1016–1020 (2013).
Kerchner, G. A. & Nicoll, R. A. Silent synapses and the emergence of a postsynaptic mechanism for LTP. Nat. Rev. Neurosci. 9, 813–825 (2008).
Woolfrey, K. M. et al. CaMKII regulates the depalmitoylation and synaptic removal of the scaffold protein AKAP79/150 to mediate structural long-term depression. J. Biol. Chem. 293, 1551–1567 (2018).
Hörtnagl, H. et al. Patterns of mRNA and protein expression for 12 GABAA receptor subunits in the mouse brain. Neuroscience 236, 345–372 (2013).
Dwivedi, D. & Bhalla, U. S. Physiology and therapeutic potential of SK, H, and M medium AfterHyperPolarization ion channels. Front. Mol. Neurosci. 14, 658435 (2021).
Kang, S. et al. Ethanol withdrawal drives anxiety-related behaviors by reducing M-type potassium channel activity in the lateral habenula. Neuropsychopharmacology 42, 1813–1824 (2017).
Winters, N. D. et al. Opposing retrograde and astrocyte-dependent endocannabinoid signaling mechanisms regulate lateral habenula synaptic transmission. Cell Rep. 42, 112159 (2023).
Zuo, W. et al. Roles of corticotropin-releasing factor signaling in the lateral habenula in anxiety-like and alcohol drinking behaviors in male rats. Neurobiol. Stress 15, 100395 (2021).
Fu, R. et al. Anxiety during alcohol withdrawal involves 5-HT2C receptors and M-channels in the lateral habenula. Neuropharmacology 163, 107863 (2020).
Zapata, A., Hwang, E.-K. & Lupica, C. R. Lateral habenula involvement in impulsive cocaine seeking. Neuropsychopharmacology 42, 1103–1112 (2017).
Flanigan, M., Aleyasin, H., Takahashi, A., Golden, S. A. & Russo, S. J. An emerging role for the lateral habenula in aggressive behavior. Pharmacol. Biochem. Behav. 162, 79–86 (2017).
Paine, T. A., Neve, R. L. & Carlezon, W. A. Attention deficits and hyperactivity following inhibition of cAMP-dependent protein kinase within the medial prefrontal cortex of rats. Neuropsychopharmacology 34, 2143–2155 (2009).
Flerlage, W. J. et al. Involvement of lateral habenula dysfunction in repetitive mild traumatic brain injury-induced motivational deficits. J. Neurotrauma 40, 125–140 (2023).
Acknowledgements
The opinions and assertions contained herein are the private opinions of the authors and are not to be construed as official or reflecting the views of the Uniformed Services University of the Health Sciences or the Department of Defense or the Government of the United States. This work was supported by the National Institute of Mental Health (NIH/NIMH) and the National Institute of Neurological Disorders and Stroke (NIH/NINDS): Grants# R21 MH132136 to FSN and R01 MH123700 and R01 NS040701 to MLD. The funding agency did not contribute to writing this article or deciding to submit it.
Author information
Authors and Affiliations
Contributions
F.S.N. and M.L.D. designed the research; S.C.S., W.J.F., L.D.L., R.D.S. and C.B. performed electrophysiology; J.L.S. was responsible for breeding ΔPKA mice; S.G. K.M.G. and E.H.T. performed immunohistochemistry. S.C.S., W.J.F. and F.S.N. analyzed the data and prepared the figures; S.C.S., W.J.F., B.M.C., M.L.D. and F.S.N. wrote the initial draft of the manuscript. All authors critically reviewed the content and approved the final version of the manuscript for submission.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest. Fereshteh Nugent is an Editorial Board Member for Communications Biology, but was not involved in the editorial review of, nor the decision to publish this article.
Peer review
Peer review information
Communications Biology thanks the anonymous reviewers for their contribution to the peer review of this work. Primary Handling Editor: Benjamin Bessieres. A peer review file is available.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Simmons, S.C., Flerlage, W.J., Langlois, L.D. et al. AKAP150-anchored PKA regulates synaptic transmission and plasticity, neuronal excitability and CRF neuromodulation in the mouse lateral habenula. Commun Biol 7, 345 (2024). https://doi.org/10.1038/s42003-024-06041-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s42003-024-06041-8
- Springer Nature Limited